- Home
- AVD vs RNXT Comparison
AVD vs RNXT Comparison
Compare AVD & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVD | RNXT |
|---|---|---|
| Founded | 1969 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 79.4M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVD | RNXT |
|---|---|---|
| Price | $1.41 | $1.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.13 |
| AVG Volume (30 Days) | 300.5K | ★ 562.7K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | 20.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $515,114,000.00 | $1,123,000.00 |
| Revenue This Year | $7.74 | $244.84 |
| Revenue Next Year | N/A | $195.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2511.63 |
| 52 Week Low | $1.61 | $0.70 |
| 52 Week High | $5.53 | $2.59 |
Technical Indicators
Market Signals| Indicator | AVD | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 15.12 | 34.20 |
| Support Level | N/A | $0.83 |
| Resistance Level | $2.41 | $1.28 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 4.85 | 1.82 |
Price Performance
Historical ComparisonAbout AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.